Biogen and AGTC team up to develop gene therapies for ophthalmic diseases
2 July 2015 | By Victoria White
Biogen and AGTC have announced a broad collaboration and license agreement to develop gene therapies for multiple ophthalmic diseases...
List view / Grid view
Drug delivery refers to approaches for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.
2 July 2015 | By Victoria White
Biogen and AGTC have announced a broad collaboration and license agreement to develop gene therapies for multiple ophthalmic diseases...
22 June 2015 | By Victoria White
ReNeuron Group has extended its ongoing research collaboration with Australia-based Benitec Biopharma following positive results in early studies...
17 June 2015 | By Victoria White
Anika Therapeutics is set to collaborate with the Institute for Applied Life Sciences at UMass to develop a therapy for rheumatoid arthritis (RA)...
9 June 2015 | By
Tillotts Pharma and Numab are to collaborate to develop and commercialise new antibody-based therapies for people with inflammatory bowel disease...
1 June 2015 | By Victoria White
Engineers at MIT and the University of California at San Diego (UCSD) have devised a way to detect liver tumours, by enlisting the help of probiotics...
21 May 2015 | By Victoria White
Alnylam has filed a Clinical Trial Application to initiate a Phase 1/2 clinical trial with ALN-AAT for the treatment of alpha-1 liver disease...
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...
6 May 2015 | By Victoria White
Dicerna Pharmaceuticals has presented positive preclinical data on its proprietary DsiRNA-EX Conjugate-mediated delivery technology at TIDES 2015...
5 May 2015 | By Victoria White
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
30 March 2015 | By Victoria White
Around 6.5 million Europeans currently suffer from AMD. Nanoparticles could potentially be used as carriers for drug treatments instead of injections...
7 November 2014 | By CARLINA Technologies
CARLINA Technologies announces the signing of a collaborative agreement with GenBiotech for the development of a prolonged-release pharmaceutical form of a protein...
The recent developments in microfluidic technology have provided an effective microreactor platform for the production of a range of pharmaceutically related materials in both nano- and micro-scale. This can be attributed to the unique characteristics that microfluidic-based reactors offer in terms of controllability and uniformity of the material characteristics, compared…
Neutrons, electrically neutral particles found within the nucleus of the atom, are coming into their own in the exploration of new ways to get drugs to their targets. Neutron techniques are being used to investigate innovative new approaches to drug delivery that could increase the effectiveness of treatments, improve the…